You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 10
  • OA-58 Associations between prenatal malaria exposure, maternal antibodies at birth and malaria susceptibility during the first year of life in Burkina Faso

Article Text

Article menu

Download PDFPDF

Abstracts of Oral Presentations
OA-58 Associations between prenatal malaria exposure, maternal antibodies at birth and malaria susceptibility during the first year of life in Burkina Faso
Free
  1. Hamtandi Magloire Natama1,
  2. Gemma Moncunill2,
  3. Marta Vidal2,
  4. Toussaint Rouamba1,
  5. Ruth Aguilar2,
  6. Rebeca Santano2,
  7. Eduard Rovira-Vallbona2,
  8. Alfons Jiménez2,
  9. M Athanase Somé1,
  10. Hermann Sorgho1,
  11. Innocent Valéa1,
  12. Maminata Coulibaly-Traoré1,
  13. Petra F Mens3,
  14. Henk DFH Schallig3,
  15. Halidou Tinto1,
  16. Anna Rosanas-Urgell4,
  17. Carlota Dobaño2
  1. 1Institut De Recherche En Sciences De La Sante – Unité De Recherche Clinique De Nanoro, Burkina Faso
  2. 2Barcelona Institute for Global Health (ISGlobal), Hospital Clínic – Universitat de Barcelona, Spain
  3. 3Academic Medical Centre at the University of Amsterdam, The Netherlands
  4. 4Department of Biomedical Sciences, Institute of Tropical Medicine, Belgium

Abstract

Background Although infants are thought to be protected against malaria during the first months of life mainly due to maternal antibodies, malaria in early childhood is not uncommon in high-transmission settings and susceptibility to Plasmodium falciparum infections varies between infants. This study aimed to investigate how different categories of prenatal malaria exposure (PME) influence levels of maternal antibodies in cord blood samples and examined the effect of maternal antibody concentrations at birth on subsequent risk of malaria in early childhood.

Methods A birth cohort study (N=661) was nested within the COSMIC clinical trial (NCT01941264) in Burkina Faso. P. falciparum infections during pregnancy and infants’ clinical malaria episodes detected during the first year of life were recorded. The levels of maternal IgG and IgG1-4 to 15 P. falciparum antigens were measured in cord blood by quantitative suspension array technology.

Results Results showed a significant variation in the magnitude of maternal antibody levels in cord blood, depending on the PME category, with past placental malaria (PM) more frequently associated with significant increases of IgG and/or subclass levels across three groups of antigens defined as pre-erythrocytic, erythrocytic and markers of PM, as compared to those from the cord of non-exposed control mothers. High levels of antibodies to certain erythrocytic antigens (EBA140, EBA175, MSP142, and MSP5) were independent predictors of protection from clinical malaria while antibodies to VAR2CSA-DBL1-2 and DBL3-4 were significantly associated with an increased malaria risk during the first year of life. Remarkably, ratios of protective-to-risk antibodies above 1 at individual level were associated with protection from clinical malaria during the first year of life.

Conclusion These findings indicate that PME categories have different effects on the levels of maternal-derived antibodies to malaria antigens in children at birth and that, this might drive heterogeneity to clinical malaria susceptibility in early childhood.

https://doi.org/10.1136/bmjgh-2023-EDC.2

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.